These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 35750295)

  • 1. Kidney organoids: a pioneering model for kidney diseases.
    Tekguc M; Gaal RCV; Uzel SGM; Gupta N; Riella LV; Lewis JA; Morizane R
    Transl Res; 2022 Dec; 250():1-17. PubMed ID: 35750295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease Modeling Using 3D Organoids Derived from Human Induced Pluripotent Stem Cells.
    Ho BX; Pek NMQ; Soh BS
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29561796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Utility of Human Kidney Organoids in Modeling Kidney Disease.
    Przepiorski A; Crunk AE; Espiritu EB; Hukriede NA; Davidson AJ
    Semin Nephrol; 2020 Mar; 40(2):188-198. PubMed ID: 32303281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Kidney organoids].
    Steichen C; Giraud S; Hauet T
    Med Sci (Paris); 2019 May; 35(5):470-477. PubMed ID: 31115331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3D kidney organoids for bench-to-bedside translation.
    Gupta N; Dilmen E; Morizane R
    J Mol Med (Berl); 2021 Apr; 99(4):477-487. PubMed ID: 33034708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in Central Nervous System Organoids: A Focus on Organoid-Based Models for Motor Neuron Disease.
    Vieira de Sá R; Cañizares Luna M; Pasterkamp RJ
    Tissue Eng Part C Methods; 2021 Mar; 27(3):213-224. PubMed ID: 33446055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Building kidney organoids from pluripotent stem cells.
    Kobayashi A; Nishinakamura R
    Curr Opin Nephrol Hypertens; 2022 Jul; 31(4):367-373. PubMed ID: 35727170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3D Engineering of Ocular Tissues for Disease Modeling and Drug Testing.
    Boutin ME; Hampton C; Quinn R; Ferrer M; Song MJ
    Adv Exp Med Biol; 2019; 1186():171-193. PubMed ID: 31654390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organoids as a new model for improving regenerative medicine and cancer personalized therapy in renal diseases.
    Grassi L; Alfonsi R; Francescangeli F; Signore M; De Angelis ML; Addario A; Costantini M; Flex E; Ciolfi A; Pizzi S; Bruselles A; Pallocca M; Simone G; Haoui M; Falchi M; Milella M; Sentinelli S; Di Matteo P; Stellacci E; Gallucci M; Muto G; Tartaglia M; De Maria R; Bonci D
    Cell Death Dis; 2019 Feb; 10(3):201. PubMed ID: 30814510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human reconstructed kidney models.
    Kishi S; Matsumoto T; Ichimura T; Brooks CR
    In Vitro Cell Dev Biol Anim; 2021 Feb; 57(2):133-147. PubMed ID: 33594607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kidney organoids in translational medicine: Disease modeling and regenerative medicine.
    Miyoshi T; Hiratsuka K; Saiz EG; Morizane R
    Dev Dyn; 2020 Jan; 249(1):34-45. PubMed ID: 30843293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stem cell-derived kidney cells and organoids: Recent breakthroughs and emerging applications.
    Chuah JKC; Zink D
    Biotechnol Adv; 2017; 35(2):150-167. PubMed ID: 28017905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Predictive Markers for the Generation of Well-Differentiated Human Induced Pluripotent Stem Cell-Derived Kidney Organoids.
    Du Z; Shankar AS; van den Bosch TPP; Korevaar SS; Clahsen-van Groningen M; Hoorn EJ; Gribnau J; Reinders MEJ; Baan CC; Hoogduijn MJ
    Stem Cells Dev; 2021 Nov; 30(22):1103-1114. PubMed ID: 34549597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pluripotent stem cell-derived kidney organoids: An in vivo-like in vitro technology.
    Schutgens F; Verhaar MC; Rookmaaker MB
    Eur J Pharmacol; 2016 Nov; 790():12-20. PubMed ID: 27375081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do not keep it simple: recent advances in the generation of complex organoids.
    Wörsdörfer P; I T; Asahina I; Sumita Y; Ergün S
    J Neural Transm (Vienna); 2020 Nov; 127(11):1569-1577. PubMed ID: 32385575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What can we learn from kidney organoids?
    Dorison A; Forbes TA; Little MH
    Kidney Int; 2022 Nov; 102(5):1013-1029. PubMed ID: 35970244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advancing preclinical drug evaluation through automated 3D imaging for high-throughput screening with kidney organoids.
    Oishi H; Tabibzadeh N; Morizane R
    Biofabrication; 2024 Apr; 16(3):. PubMed ID: 38547531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regenerative Medicine, Disease Modeling, and Drug Discovery in Human Pluripotent Stem Cell-derived Kidney Tissue.
    Gupta N; Susa K; Morizane R
    Eur Med J Reprod Health; 2017 Aug; 3(1):57-67. PubMed ID: 31157117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Creating a kidney organoid-vasculature interaction model using a novel organ-on-chip system.
    Bas-Cristóbal Menéndez A; Du Z; van den Bosch TPP; Othman A; Gaio N; Silvestri C; Quirós W; Lin H; Korevaar S; Merino A; Mulder J; Hoogduijn MJ
    Sci Rep; 2022 Nov; 12(1):20699. PubMed ID: 36450835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A fully automated high-throughput workflow for 3D-based chemical screening in human midbrain organoids.
    Renner H; Grabos M; Becker KJ; Kagermeier TE; Wu J; Otto M; Peischard S; Zeuschner D; TsyTsyura Y; Disse P; Klingauf J; Leidel SA; Seebohm G; Schöler HR; Bruder JM
    Elife; 2020 Nov; 9():. PubMed ID: 33138918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.